Mechanisms of disease: Primary Sjögren's syndrome and the type I interferon system

Nature Clinical Practice Rheumatology

Volumn 2, Issue 5, 2006, Pages 262-269

  Nordmark, Gunnel ^a   Alm, Gunnar V ^b   Rönnblom, Lars ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Interferon ; Natural interferon producing cell; Plasmacytoid dendritic cell; Sj syndrome; Type I interferon

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CEVIMELINE; CHEMOKINE; FC RECEPTOR; GAMMA INTERFERON; GRANZYME B; HYDROXYCHLOROQUINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; LA ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 3; PILOCARPINE; PROTEIN BAX; PROTEIN BCL 2; RITUXIMAB; RNA BINDING PROTEIN; RO ANTIBODY; SALIVA SUBSTITUTE; SMALL NUCLEAR RNA; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ACINAR CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEFENSE MECHANISM; DENDRITIC CELL; DRY EYE; EFFECTOR CELL; EPITHELIUM CELL; HODGKIN DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LACRIMAL GLAND; LUNG ALVEOLITIS; LYMPHOMA; MACROPHAGE; MALIGNANT TRANSFORMATION; MYOSITIS; NEPHRITIS; NEUROPATHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SALIVARY GLAND BIOPSY; SALIVATION DISORDER; SJOEGREN SYNDROME; T LYMPHOCYTE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CHEMOKINES, CXC; DENDRITIC CELLS; GENES, MHC CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 33646459191     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0173     Document Type: Review

References (56)

1. Fox RI (2005) Sjögren's syndrome. Lancet 366: 321-331
2. Vitali C et al. (2002) Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61: 554-558
3. Bowman SJ et al. (2004) Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 33: 39-43
4. Kassan SS et al. (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89: 888-892
5. James J et al. (2001) Role of viruses in systemic lupus erythematosus and Sjögren syndrome. Curr Opin Rheumatol 13: 370-376
6. Ramos-Casals M et al. (2005) Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: Linking infection, autoimmunity and cancer. Autoimmunity Rev 4: 8-15
7. Tzioufas AG et al. (2002) Clinical, immunological and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): A European multicentre study. Ann Rheum Dis 61: 398-404
8. Brennan MT et al. (2003) Sex steroid hormones in primary Sjögren's syndrome. J Rheumatol 30: 1267-1271
9. Dörner T and Lipsky PE (2002) Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res 4: 360-371
10. Båve U et al. (2005) Activation of the type I interferon system in primary Sjögren's syndrome - a possible etiopathogenic mechanism. Arthritis Rheum 52: 1185-1195
11. Soliotis FC and Moutsopoulos HM (2004) Sjögren's syndrome. Autoimmunity 37: 305-307
12. Migliorini P et al. (2005) Anti-Sm and anti-RNP antibodies. Autoimmunity 38: 47-54
13. Prochorec-Sobieszek M et al. (2004) Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome. Med Sci Monit 10: BR115-BR121
14. Amft N et al. (2001) Ectopic expression of the B cell attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum 44: 2633-2641
15. Vanbervliet B et al. (2003) The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198: 823-830
16. Salomonsson S et al. (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 48: 3187-3201
17. Groom J et al. (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 109: 59-68
18. Stott DI et al. (1998) Antigen-driven clonal proliferation of B-cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest 102: 938-946
19. Salomonsson S and Wahren-Herlenius M (2003) Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjögren's syndrome. Scand J Rheumatol 32: 79-82
20. Rowe D et al. (1987) HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann Rheum Dis 46: 580-586
21. Ohlsson M et al. (2002) CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary gland cells: A putative anti-apoptotic role during its effector phases. Scand J Immunol 56: 561-571
22. Turkcapar N et al. (2005) Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome. J Rheumatol 32: 1063-1070
23. Manoussakis MN et al. (1999) Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 42: 229-239
24. Kong L et al. (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40: 87-97
25. Ohlsson M et al. (2001) Fas-induced apoptosis is a rare event in Sjögren's syndrome. Lab Invest 81: 95-105
26. Ulbricht KU et al. (2003) Antibodies against alpha-fodrin in Sjögren's syndrome. Autoimmuniry Rev 2: 109-113
27. McArthur C et al. (2002) Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly (ADP-ribose) polymerase and α-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumor necrosis factor-α. Arch Oral Biol 47: 443-448
28. Szodoray P et al. (2005) Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 117: 168-176
29. Hjelmervik TOR et al. (2005) Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 52: 1534-1544
30. Gottenberg J-E et al. (2005) Innate immunity and interferon signalling pathways: A pivotal pathogenic role in epithelial cells of salivary glands and ocular surfaces in primary Sjögren's syndrome [abstract]. Arthritis Rheum 52: S278-S279
31. Emamian ES et al. (2005) Gene expression profiling of Sjogren patients is distinctly different from sicca patients [abstract]. Arthritis Rheum 52: S277-S278
32. Rönnblom L et al. (2003) Role of natural interferon-α producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36: 463-472
33. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809
34. Rönnblom L and Alm GV (2002) The natural interferon-α producing cells in systemic lupus erythematosus. Human Immunol 63: 1181-1193
35. Theofilopoulos A et al. (2005) Type I interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336
36. Farkas L et al. (2001) Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 159: 237-243
37. Devendra D and Eisenbarth GS (2004) Interferon alpha - a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 111: 225-233
38. Lande R et al. (2004) Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol 173: 2815-2824
39. Greenberg SA et al. (2005) Interferon-α/β-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664-678
40. Nestle FO et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med 202: 135-143
41. Takii Y et al. (2005) Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest 85: 908-920
42. Gota C and Calabrese L (2003) Induction of clinical autoimmune disease by therapeutic interferon-α. Autoimmunity 36: 511-518
43. Bennett L et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197: 711-723
44. Hunziker L et al. (2003) Hypergammaglobulinemia and autoantibody induction mechanisms in viral infection. Nat Immunol 4: 931-932
45. Båve U et al. (2003) FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J Immunol 171: 3296-3302
46. Means TK et al. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TRL9. J Clin Invest 115: 407-417
47. Kirou KA et al. (2000) Induction of Fas-mediated apoptosis by interferon-α. Clin Immunol 95: 218-226
48. Salomonsson S et al. (2005) Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201: 11-17
49. Pijpe J et al. (2005) Rituximab treatment in patients with primary Sjögren's syndrome. Arthritis Rheum 52: 2740-2750
50. Dzionek A et al. (2001) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J Exp Med 194: 1823-1834
51. Blomberg S et al. (2003) Expression of the markers BDCA-2 and BDCA-4 and production of interferon-α by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 48: 2524-2532
52. Cummins MJ et al. (2003) Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 49: 585-593
53. Ferraccioli GF et al. (1996) Interferon alpha-2 (IFNα2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin Exp Rheumatol 14: 367-371
54. Yamada S et al. (2005) Interferon alfa treatment for Sjögren's syndrome associated neuropathy. J Neurol Neurosurg Psychiatry 76: 576-578
55. Fox RI et al. (1994) Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152: 5532-5539
56. Ogawa N et al. (2004) Expression of interferon-inducible T cell α chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome. Clin Immunol 112: 235-238